Investment Newsletters

Aurora Cannabis Stock Is Under the Hammer; Here’s What You Need to KnowSeptember 16, 2020

3 Cannabis Stocks to Benefit From a Biden PresidencyJuly 31, 2020

deal

Aurora Cannabis (ACB): Beneficial Canadian Cannabis Cons...July 23, 2020

3 Cannabis Stocks to Benefit From New York Recreational ...July 15, 2020

Aurora Cannabis (ACB): Transformation on TrackJuly 10, 2020

Gary Bourgeault

• August 7, 2019

Did Aphria (APHA) Save the Cannabis Sector?

After hearing the latest earnings report from Aphria (APHA), it was good to see the company appear to start turning things around. Even so, the response from...

Stone Fox Capital

• August 6, 2019

Aurora Cannabis (ACB): Will $6 Hold?

A few days following a dip into the $5s, Aurora Cannabis (ACB) stock has seen a reprieve due to the perceived strong numbers from Aphria (APHA) and positive...

Gary Bourgeault

• August 6, 2019

Aurora Cannabis (ACB) Stock Gets Its Mojo Back; What’s Next?

After some scandals and weak earnings reports rocked the cannabis industry over the last couple of months, most of the companies competing in the sector...

Gary Bourgeault

• August 6, 2019

CannTrust (CTST) Stock Remains in a State of Limbo

As the ongoing fallout from the debacle surrounding CannTrust (CTST) continues to create increasing uncertainty concerning its future and even survival, it...

Departures Capital

• August 6, 2019

Don’t Get Too Excited About Cronos Group (CRON) Stock Just Yet: Jeffries

Cronos Group (CRON) has been up to a lot of things recently and part of that has been to do with the US CBD market. Indeed, last week the company announced...

Departures Capital

• August 6, 2019

Aphria (APHA) Stock: Next Stop, $13?

It's safe to say that Aphria (APHA) totally shocked the market and many of its investors after blowing its fiscal fourth-quarter earnings out of the...

Gary Bourgeault

• August 5, 2019

After the Drama, Where Are Canopy Growth (CGC) and the Cannabis Sector Headed Now?

Since the announcement that Constellation Brands fired Canopy Growth (CGC) co-CEO Bruce Linton, the cannabis sector has been under immense pressure, as the...

Stone Fox Capital

• August 5, 2019

Aphria’s (APHA) Earnings Report Wasn’t Exactly a Blockbuster, But Upside Remains

By all accounts, Aphria (APHA) reported a better than expected FQ4 quarter for the period ending May 31. The Canadian cannabis company was under substantial...

Stone Fox Capital

• August 5, 2019

Trulieve: Slow and Steady Wins The Race

With Trulieve Cannabis (TCNNF) generating revenue growth in excess of 100%, one wouldn’t normally associate the company with slow and steady growth. In the...

Gary Bourgeault

• August 5, 2019

Aurora Cannabis (ACB) and its Hidden Value

Aurora Cannabis (ACB) is the top cannabis company in the world in my opinion, although admittedly, it's a difficult company to value because of its decision to...

« 1 … 23 24 25 26 27 … 56 »

CANNABIS STOCKS

DAILY PERFORMANCE

Market Overview

Cannabis is in process of changing from an illegal controlled substance to a major industry. Mounting political pressure over the past decade, along with increasing political clout of the post-60s generation, has pushed legalization across North America. In the US, several states led the way by legalizing cannabis for medical use in the 1990s, and starting in 2012, a trend toward both decriminalization and legalization has led to 10 states legalizing the substance for all uses. Canada enacted a nation-wide measure for full legalization in October 2018, after legalizing medical use in 2014. Several European countries, and Australia, also have limited legalization regimes for cannabis.

Existing medical-use companies have branched into the recreational sector, production companies have increased their growing acreage, and distribution networks are starting to form – that last is hampered by the fact that cannabis and marijuana products are still illegal at the US Federal level, effectively preventing interstate trade.

From an investor perspective, all of this has had a predictable effect on the nascent cannabis industry. The market cap of the largest cannabis stocks has ballooned past $20 billion. For now, the volatility of the cannabis market, the rapid growth in distribution and sales, and the prospect that more US states will pursue full or partial legalization regimes, all combine to make cannabis stocks a popular choice for investors willing to take on risk.

Globally, the cannabis/marijuana industry may be worth an estimated $150 billion dollars. It’s not quite there yet, but the large cannabis companies are growing rapidly. The six largest account for over $40 billion in combined market cap. Canopy Growth (CGC) is the largest of the cannabis stocks. The company’s main focus is supplying the Canadian market for recreational use.

Next up is Aurora Cannabis (ACB). Aurora produces over 500,000 kilograms of cannabis products annually, primarily for the medical market.

Cronos (CRON) is a fast-growing producer in Canada. The company recently entered a venture project to more than double its production capabilities.

Tilray (TLRY) is a newcomer to the field, having gone public in July 2018. The company already has more than 3 million square feet of land at its disposal for cultivation.

Last but not the least, Aphria (APHA) is an Ontario-based cannabis company worth $2.53 billion. That market cap is backed by a production capacity of over 240,000 kilograms per year.